Supriya Lifesci.

{
  "main_header": {
    "sid": 1003587,
    "name": "Supriya Lifesci.",
    "stock_name": "Supriya Lifesci.",
    "full_name": "Supriya Lifescience Ltd",
    "name_url": "stocks-analysis/supriya-lifesci",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "662.30",
    "chg": -21.7,
    "chgp": "-3.17%",
    "dir": -1,
    "prev_price": "684.00",
    "mcapval": "5,417.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543434,
    "symbol": "SUPRIYA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE07RO01027",
    "curr_date": "Jan 28",
    "curr_time": "",
    "bse_nse_vol": "2.43 lacs",
    "exc_status": "Active",
    "traded_date": "Jan 28, 2026",
    "traded_date_str": "2026 01 28",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/supriya-lifesci-1003587-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Supriya Lifescience Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-ltd-is-rated-hold-by-marketsmojo-3798311",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SupriyaLifescie_mojoScore_3798311.png",
        "date": "2026-01-21 10:10:03",
        "description": "Supriya Lifescience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Supriya Lifescience Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3789345",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SupriyaLifescie_technicaldot_3789345.png",
        "date": "2026-01-12 08:04:06",
        "description": "Supriya Lifescience Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, reflected in a downgrade from a Sell to a Hold rating by MarketsMOJO on 20 Oct 2025. Despite a recent 3.55% decline in share price, the stock’s technical indicators reveal a complex picture of mildly bullish and bearish signals across different timeframes, suggesting cautious optimism among investors."
      },
      {
        "title": "Supriya Lifescience Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-ltd-is-rated-hold-by-marketsmojo-3788135",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SupriyaLifescie_mojoScore_3788135.png",
        "date": "2026-01-10 10:10:05",
        "description": "Supriya Lifescience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 January 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing."
      },
      {
        "title": "Supriya Lifescience Ltd Shows Bullish Momentum Amid Technical Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-shows-bullish-momentum-amid-technical-upgrades-3786446",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SupriyaLifescie_technicaldot_3786446.png",
        "date": "2026-01-09 08:09:12",
        "description": "Supriya Lifescience Ltd has demonstrated a notable shift in price momentum, moving from a mildly bullish to a bullish technical trend, supported by a mix of positive signals from key indicators such as moving averages and Bollinger Bands. Despite some mixed signals from MACD and KST, the stock’s recent performance and technical upgrades suggest growing investor confidence within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Supriya Lifescience Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-ltd-is-rated-hold-by-marketsmojo-3774968",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SupriyaLifescie_mojoScore_3774968.png",
        "date": "2025-12-30 10:10:04",
        "description": "Supriya Lifescience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 December 2025, providing investors with an up-to-date perspective on its performance and outlook."
      },
      {
        "title": "Supriya Lifescience Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-technical-momentum-shifts-amid-mixed-indicator-signals-3772679",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SupriyaLifescie_technicaldot_3772679.png",
        "date": "2025-12-29 08:06:08",
        "description": "Supriya Lifescience has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of indicator signals across multiple timeframes. The stock’s recent price action and technical parameters suggest a transition from a bullish stance to a more cautiously optimistic outlook, with key metrics such as MACD, RSI, and moving averages providing a mixed but insightful picture for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Supriya Lifescience Technical Momentum Shifts Signal Changing Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-technical-momentum-shifts-signal-bullish-outlook-amid-mixed-indicators-3767826",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SupriyaLifescie_technicaldot_3767826.png",
        "date": "2025-12-24 08:17:24",
        "description": "Supriya Lifescience has exhibited notable shifts in its technical momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. Recent assessment changes highlight a transition in price momentum and technical indicators, suggesting a nuanced outlook for investors analysing this stock."
      },
      {
        "title": "Supriya Lifesci. Sees Revision in Market Evaluation Amidst Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifesci-upgraded-from-sell-to-hold-by-marketsmojo-on-20-oct-2025-3763855",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SupriyaLifesci_mojoScore_3763855.png",
        "date": "2025-12-19 10:10:05",
        "description": "Supriya Lifesci., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting nuanced shifts across key analytical parameters. This adjustment highlights evolving perspectives on the company’s quality, valuation, financial trends, and technical outlook, providing investors with a refreshed framework to assess its market position."
      },
      {
        "title": "Supriya Lifescience Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-technical-momentum-shifts-amid-mixed-indicator-signals-3747819",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SupriyaLifescie_technicaldot_3747819.png",
        "date": "2025-12-05 08:11:10",
        "description": "Supriya Lifescience, a notable player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of indicator signals across multiple timeframes. Recent evaluation adjustments reveal a transition from a bullish to a mildly bullish trend, with key technical parameters such as MACD, RSI, and moving averages presenting a mixed picture for investors analysing the stock’s near-term trajectory."
      }
    ],
    "total": 271,
    "sid": "1003587",
    "stock_news_url": "https://www.marketsmojo.com/news/supriya-lifescience-1003587"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Supriya Lifescience Ltd has declared <strong>50%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Supriya Lifescience Ltd is Rated Hold by MarketsMOJO

2026-01-21 10:10:03

Supriya Lifescience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Supriya Lifescience Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-01-12 08:04:06

Supriya Lifescience Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, reflected in a downgrade from a Sell to a Hold rating by MarketsMOJO on 20 Oct 2025. Despite a recent 3.55% decline in share price, the stock’s technical indicators reveal a complex picture of mildly bullish and bearish signals across different timeframes, suggesting cautious optimism among investors.

Read full news article

Supriya Lifescience Ltd is Rated Hold by MarketsMOJO

2026-01-10 10:10:05

Supriya Lifescience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 January 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing.

Read full news article

Supriya Lifescience Ltd Shows Bullish Momentum Amid Technical Upgrades

2026-01-09 08:09:12

Supriya Lifescience Ltd has demonstrated a notable shift in price momentum, moving from a mildly bullish to a bullish technical trend, supported by a mix of positive signals from key indicators such as moving averages and Bollinger Bands. Despite some mixed signals from MACD and KST, the stock’s recent performance and technical upgrades suggest growing investor confidence within the Pharmaceuticals & Biotechnology sector.

Read full news article

Supriya Lifescience Ltd is Rated Hold by MarketsMOJO

2025-12-30 10:10:04

Supriya Lifescience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 December 2025, providing investors with an up-to-date perspective on its performance and outlook.

Read full news article

Supriya Lifescience Technical Momentum Shifts Amid Mixed Indicator Signals

2025-12-29 08:06:08

Supriya Lifescience has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of indicator signals across multiple timeframes. The stock’s recent price action and technical parameters suggest a transition from a bullish stance to a more cautiously optimistic outlook, with key metrics such as MACD, RSI, and moving averages providing a mixed but insightful picture for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Supriya Lifescience Technical Momentum Shifts Signal Changing Market Dynamics

2025-12-24 08:17:24

Supriya Lifescience has exhibited notable shifts in its technical momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. Recent assessment changes highlight a transition in price momentum and technical indicators, suggesting a nuanced outlook for investors analysing this stock.

Read full news article

Supriya Lifesci. Sees Revision in Market Evaluation Amidst Mixed Financial Signals

2025-12-19 10:10:05

Supriya Lifesci., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting nuanced shifts across key analytical parameters. This adjustment highlights evolving perspectives on the company’s quality, valuation, financial trends, and technical outlook, providing investors with a refreshed framework to assess its market position.

Read full news article

Supriya Lifescience Technical Momentum Shifts Amid Mixed Indicator Signals

2025-12-05 08:11:10

Supriya Lifescience, a notable player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of indicator signals across multiple timeframes. Recent evaluation adjustments reveal a transition from a bullish to a mildly bullish trend, with key technical parameters such as MACD, RSI, and moving averages presenting a mixed picture for investors analysing the stock’s near-term trajectory.

Read full news article

View All News